These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30496303)

  • 1. Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction.
    Dicks MDJ; Betancor G; Jimenez-Guardeño JM; Pessel-Vivares L; Apolonia L; Goujon C; Malim MH
    PLoS Pathog; 2018 Nov; 14(11):e1007408. PubMed ID: 30496303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.
    Goujon C; Moncorgé O; Bauby H; Doyle T; Barclay WS; Malim MH
    J Virol; 2014 Aug; 88(16):9017-26. PubMed ID: 24899177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SAMHD1-MX2 axis restricts HIV-1 infection at postviral DNA synthesis.
    Guo H; Yang W; Li H; Yang J; Huang Y; Tang Y; Wang S; Ni F; Yang W; Yu X-F; Wei W
    mBio; 2024 Jul; 15(7):e0136324. PubMed ID: 38888311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection.
    Dicks MD; Goujon C; Pollpeter D; Betancor G; Apolonia L; Bergeron JR; Malim MH
    J Virol; 2016 Jan; 90(1):22-32. PubMed ID: 26446602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2.
    Kane M; Rebensburg SV; Takata MA; Zang TM; Yamashita M; Kvaratskhelia M; Bieniasz PD
    Elife; 2018 Aug; 7():. PubMed ID: 30084827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 resists MxB inhibition of viral Rev protein.
    Wang Z; Chai K; Liu Q; Yi DR; Pan Q; Huang Y; Tan J; Qiao W; Guo F; Cen S; Liang C
    Emerg Microbes Infect; 2020 Dec; 9(1):2030-2045. PubMed ID: 32873191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid.
    Xu F; Zhao F; Zhao X; Zhang D; Liu X; Hu S; Mei S; Fan Z; Huang Y; Sun H; Wei L; Wu C; Li Q; Wang J; Cen S; Liang C; Guo F
    J Biol Chem; 2020 May; 295(19):6447-6456. PubMed ID: 32217692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6.
    Xie L; Chen L; Zhong C; Yu T; Ju Z; Wang M; Xiong H; Zeng Y; Wang J; Hu H; Hou W; Feng Y
    Retrovirology; 2020 Jun; 17(1):16. PubMed ID: 32600399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
    Ji S; Na L; Ren H; Wang Y; Wang X
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
    Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
    Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation.
    Betancor G; Bangham M; Jeon JK; Shah K; Lynham S; Jimenez-Guardeño JM; Malim MH
    mBio; 2022 Aug; 13(4):e0171422. PubMed ID: 35880880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    Layish B; Goli R; Flick H; Huang SW; Zhang RZ; Kvaratskhelia M; Kane M
    PLoS Pathog; 2024 Mar; 20(3):e1011830. PubMed ID: 38512975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MX2 is an interferon-induced inhibitor of HIV-1 infection.
    Kane M; Yadav SS; Bitzegeio J; Kutluay SB; Zang T; Wilson SJ; Schoggins JW; Rice CM; Yamashita M; Hatziioannou T; Bieniasz PD
    Nature; 2013 Oct; 502(7472):563-6. PubMed ID: 24121441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity.
    Xie L; Ju Z; Zhong C; Wu Y; Zan Y; Hou W; Feng Y
    Virol Sin; 2021 Feb; 36(1):85-94. PubMed ID: 32632818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
    Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
    J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.
    Steiner F; Pavlovic J
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32907985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction.
    Betancor G; Dicks MDJ; Jimenez-Guardeño JM; Ali NH; Apolonia L; Malim MH
    Cell Rep; 2019 Nov; 29(7):1923-1933.e3. PubMed ID: 31722207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host and viral determinants for MxB restriction of HIV-1 infection.
    Matreyek KA; Wang W; Serrao E; Singh PK; Levin HL; Engelman A
    Retrovirology; 2014 Oct; 11():90. PubMed ID: 25348155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let me in: Control of HIV nuclear entry at the nuclear envelope.
    Bhargava A; Lahaye X; Manel N
    Cytokine Growth Factor Rev; 2018 Apr; 40():59-67. PubMed ID: 29526438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells.
    Levin A; Hayouka Z; Friedler A; Loyter A
    Nucleus; 2010; 1(5):422-31. PubMed ID: 21326825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.